Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,073 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use of roflumilast in COPD: a primary care perspective.
Price D, Chisholm A, Ryan D, Crockett A, Jones R. Price D, et al. Among authors: jones r. Prim Care Respir J. 2010 Dec;19(4):342-51. doi: 10.4104/pcrj.2010.00066. Prim Care Respir J. 2010. PMID: 21085915 Free PMC article. Review.
GOLD COPD categories are not fit for purpose in primary care.
Jones R, Price D, Chavannes N, van de Molen T, Thomas M, Tsiligianni I, Williams S. Jones R, et al. Lancet Respir Med. 2013 Mar;1(1):e17. doi: 10.1016/S2213-2600(13)70015-8. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321812 No abstract available.
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.
Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group. Jones RC, et al. Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13. Lancet Respir Med. 2014. PMID: 24717623 Free article.
Predicting frequent COPD exacerbations using primary care data.
Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB; Respiratory Effectiveness Group. Kerkhof M, et al. Among authors: jones r. Int J Chron Obstruct Pulmon Dis. 2015 Nov 9;10:2439-50. doi: 10.2147/COPD.S94259. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26609229 Free PMC article.
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.
Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D. Gruffydd-Jones K, et al. Among authors: jones r. NPJ Prim Care Respir Med. 2016 Feb 25;26:16002. doi: 10.1038/npjpcrm.2016.2. NPJ Prim Care Respir Med. 2016. PMID: 28358398 Free PMC article.
Blood eosinophil count and exacerbation risk in patients with COPD.
Kerkhof M, Sonnappa S, Postma DS, Brusselle G, Agustí A, Anzueto A, Jones R, Papi A, Pavord I, Pizzichini E, Popov T, Roche N, Ryan D, Thomas M, Vogelmeier C, Chisholm A, Freeman D, Bafadhel M, Hillyer EV, Price DB. Kerkhof M, et al. Among authors: jones r. Eur Respir J. 2017 Jul 20;50(1):1700761. doi: 10.1183/13993003.00761-2017. Print 2017 Jul. Eur Respir J. 2017. PMID: 28729477 Free article. No abstract available.
18,073 results
You have reached the last available page of results. Please see the User Guide for more information.